Europe — EMA
Nebilet (Nebivolol)
GNH USA supplies Nebilet (Nebivolol), a beta blocker for hypertension and heart failure, approved in the EU. Request a quote for global supply today.
Request sourcing
What is Nebivolol?
Nebivolol, the active ingredient in Nebilet, is a beta blocker presented as a tablet for oral use. It treats hypertension and heart failure in adult patients.
GNH USA supplies Nebilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Nebivolol used for?
Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular disease management.
Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. Heart failure: improves left‑ventricular function and may decrease hospitalization rates. Cardiovascular risk management: contributes to overall risk reduction in patients with multiple risk factors.
What are the side effects of Nebivolol?
Nebivolol may cause a range of adverse reactions, most of which are mild and transient.
Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially on standing. - Fatigue or general tiredness. - Bradycardia: heart rate slower than normal. - Nausea or mild gastrointestinal upset.
Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to syncope. - Bronchospasm in patients with reactive airway disease. - Allergic reactions such as rash, angioedema, or anaphylaxis. - Worsening heart failure symptoms.
What precautions apply to Nebivolol?
Before initiating Nebivolol, consider the following safety measures. - Renal impairment: dose adjustment may be required in severe dysfunction. - Hepatic impairment: use with caution; monitor liver function. - Asthma or COPD: avoid in patients with active bronchospasm. - Concomitant beta‑blockers: assess risk of additive bradycardia. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original pack, protect from moisture.
What does Nebivolol interact with?
Nebivolol can interact with several drug classes; monitoring is essential.
Major Interactions (Avoid): - Non‑selective beta‑blockers: risk of excessive β‑blockade. - Calcium‑channel blockers (verapamil, diltiazem): may cause profound bradycardia or AV block. - Clonidine withdrawal: can precipitate severe hypertension.
Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive hypotensive effect. - Diuretics: may enhance blood‑pressure lowering. - Antidiabetic agents: monitor glucose as beta‑blockade can mask hypoglycaemia symptoms.



